WHITEHAWK THERAPEUTICS, INC.: 10-Q filed 2020-11-10

Name: WHITEHAWK THERAPEUTICS, INC.: 10-Q filed 2020-11-10
Creator: WHITEHAWK THERAPEUTICS, INC.

What WHITEHAWK THERAPEUTICS, INC. reported in its quarterly report filed 2020-11-10 (fiscal Q3 2020): 32 published measures, 95 facts as tagged in accession 0001564590-20-052756.

This filing

Form: 10-Q (quarterly report)
Filed: 2020-11-10
Fiscal period: fiscal Q3 2020
Accession: 0001564590-20-052756 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All WHITEHAWK THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2020-09-30	49,830,378	USD
At 2019-12-31	39,936,786	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2020-09-30	2,511,959	USD
At 2019-12-31	3,401,443	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2020-09-30	47,318,419	USD
At 2020-06-30	42,600,459	USD
At 2020-03-31	33,006,494	USD
At 2019-12-31	36,535,343	USD
At 2019-09-30	41,714,449	USD
At 2019-06-30	45,716,480	USD
At 2019-03-31	50,795,435	USD
At 2018-12-31	58,666,575	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2020-09-30	47,281,986	USD
At 2019-12-31	38,524,536	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	-4,955,023	USD	92
2020-01-01 to 2020-09-30	402,346	USD	274
2020-04-01 to 2020-06-30	9,276,032	USD	91
2020-01-01 to 2020-03-31	-3,918,663	USD	91
2019-07-01 to 2019-09-30	-4,647,930	USD	92
2019-01-01 to 2019-09-30	-18,824,371	USD	273
2019-04-01 to 2019-06-30	-5,683,616	USD	91
2019-01-01 to 2019-03-31	-8,492,825	USD	90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2020-01-01 to 2020-09-30	-564,367	USD	274
2019-01-01 to 2019-09-30	-18,987,454	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2020-01-01 to 2020-09-30	19,025	USD	274
2019-01-01 to 2019-09-30	236,953	USD	273

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	0	USD	92
2020-01-01 to 2020-09-30	15,000,000	USD	274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2020-01-01 to 2020-09-30	9,340,842	USD	274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2020-01-01 to 2020-09-30	-19,025	USD	274
2019-01-01 to 2019-09-30	-236,953	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2020-09-30	-141,833,176	USD
At 2019-12-31	-142,235,522	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	42,139,493	shares	92
2020-01-01 to 2020-09-30	41,108,942	shares	274
2019-07-01 to 2019-09-30	40,588,004	shares	92
2019-01-01 to 2019-09-30	40,588,004	shares	273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	42,139,493	shares	92
2020-01-01 to 2020-09-30	41,477,388	shares	274
2019-07-01 to 2019-09-30	40,588,004	shares	92
2019-01-01 to 2019-09-30	40,588,004	shares	273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2020-09-30	137,325	USD
At 2019-12-31	164,187	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	332,141	USD	92
2020-01-01 to 2020-09-30	967,949	USD	274
2019-07-01 to 2019-09-30	645,899	USD	92
2019-01-01 to 2019-09-30	1,872,245	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	-5,861,403	USD	92
2020-01-01 to 2020-09-30	-720,423	USD	274
2019-07-01 to 2019-09-30	-4,966,638	USD	92
2019-01-01 to 2019-09-30	-19,786,849	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2020-09-30	49,583,292	USD
At 2019-12-31	39,570,475	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2020-09-30	2,511,959	USD
At 2019-12-31	3,334,005	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2020-09-30	709,272	USD
At 2019-12-31	439,785	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	5,861,403	USD	92
2020-01-01 to 2020-09-30	15,720,423	USD	274
2019-07-01 to 2019-09-30	4,966,638	USD	92
2019-01-01 to 2019-09-30	19,786,849	USD	273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	3,985,988	USD	92
2020-01-01 to 2020-09-30	9,363,602	USD	274
2019-07-01 to 2019-09-30	2,844,603	USD	92
2019-01-01 to 2019-09-30	10,695,109	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2020-09-30	47,111,659	shares
At 2019-12-31	40,588,004	shares

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2020-09-30	89,761	USD
At 2019-12-31	162,124	USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

Period	Value	Unit	Days
At 2020-09-30	94,787	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2020-01-01 to 2020-09-30	402,346	USD	274
2019-01-01 to 2019-09-30	-18,824,371	USD	273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	1,875,415	USD	92
2020-01-01 to 2020-09-30	6,356,821	USD	274
2019-07-01 to 2019-09-30	2,160,845	USD	92
2019-01-01 to 2019-09-30	8,215,456	USD	273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2020-01-01 to 2020-09-30	45,887	USD	274
2019-01-01 to 2019-09-30	53,692	USD	273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	906,380	USD	92
2020-01-01 to 2020-09-30	1,122,769	USD	274
2019-07-01 to 2019-09-30	318,708	USD	92
2019-01-01 to 2019-09-30	962,478	USD	273

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

Period	Unit	Days
2020-07-01 to 2020-09-30	USD	92
2020-01-01 to 2020-09-30	USD	274
2019-07-01 to 2019-09-30	USD	92
2019-01-01 to 2019-09-30	USD	273

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Unit	Days
2020-07-01 to 2020-09-30	USD	92
2020-01-01 to 2020-09-30	USD	274
2019-07-01 to 2019-09-30	USD	92
2019-01-01 to 2019-09-30	USD	273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2020-01-01 to 2020-09-30	9,743,637	USD	274

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

Period	Value	Unit	Days
2020-07-01 to 2020-09-30	29,625	USD	92
2020-01-01 to 2020-09-30	87,915	USD	274
2019-07-01 to 2019-09-30	62,634	USD	92
2019-01-01 to 2019-09-30	186,942	USD	273

Inspect the source

Entity: WHITEHAWK THERAPEUTICS, INC. / CIK 0001422142
Captured: 2026-09-20 08:03 UTC
SEC response SHA-256: 0bc3518b433577b57088b38c087953d494e28bdd319b1da3b435ea8e7e18b0c1

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001422142.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))